The FDA has approved a generic daily injectable, the liraglutide injection, for patients aged 10 years and up who have Type 2 diabetes. This injectable, sold under the name Victoza, which is currently in short supply, offers a more affordable solution for those requiring GLP-1 medications. However, patients with particular medical conditions are advised against using the medicine.
Apache Parquet Java Vulnerability Let Attackers Execute Arbitrary Code
A critical vulnerability (CVE-2025-46762) in Apache Parquet Java allows arbitrary code execution via crafted Parquet files. Affecting all versions up to 1.15.1, it primarily concerns
